If you have a history of breast cancer and a mutation in the CHEK2 gene, you may be eligible to contribute to tumor genomics studies to help better understand inherited breast cancer in CHEK2 carriers. Through the Inherited Cancer Registry (ICARE), we are studying: - breast cancer characteristics - factors associated with outcomes, including treatments - tumor genomics to better understand pathways to tumor development With your help, we hope that one day our research may lead to new or refined

check2check on Reels

If you have a history of breast cancer and a mutation in an inherited breast cancer gene (i.e., BRCA1/2, PALB2, ATM, or CHEK2), you may be eligible to contribute to tumor genomics studies that are being conducted through the Inherited Cancer Registry (ICARE). Through this effort, we are researching: - breast cancer characteristics - factors associated with outcomes, including treatments - studying genomics of the tumors to better understand pathways to tumor development, which can hopefully lead

Do you have a history of breast cancer and a mutation in an inherited breast cancer gene (i.e., BRCA1, BRCA2, PALB2, ATM, and/or CHEK2)? Please consider joining our study at https://redcap.link/ICAREconsent if you have an inherited breast cancer gene mutation. In those with a breast cancer diagnosis, we are doing free genomic testing on tumor samples to better understand inherited breast cancers. Once you enroll in our study, we will assess your eligibility for this and other focused research ef